01 1CTX Lifesciences Pvt. Ltd.
01 1Xylometazoline Hydrochloride
01 1India
NDC Package Code : 42419-004
Start Marketing Date : 2008-09-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
A Xylometazoline Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Xylometazoline Hydrochloride, including repackagers and relabelers. The FDA regulates Xylometazoline Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Xylometazoline Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Xylometazoline Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Xylometazoline Hydrochloride supplier is an individual or a company that provides Xylometazoline Hydrochloride active pharmaceutical ingredient (API) or Xylometazoline Hydrochloride finished formulations upon request. The Xylometazoline Hydrochloride suppliers may include Xylometazoline Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Xylometazoline Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Xylometazoline Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Xylometazoline Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Xylometazoline Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Xylometazoline Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Xylometazoline Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Xylometazoline Hydrochloride suppliers with NDC on PharmaCompass.
We have 1 companies offering Xylometazoline Hydrochloride
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
